Skip to content
Rameda Pharma
Rameda Pharma
  • IR Library
    • Results Center
    • Presentations and Publications
    • Board and Shareholders Actions
    • Our People
  • Share & Corporate Information
    • Key Information
    • Listing Information
    • Analyst Coverage
  • News and Disclosures
    • Corporate News
    • Regulatory Disclosures
  • IR Calendar
  • Corporate Governance
    • BOD Reports
    • Corporate Governance Reports
  • IR Contact
Corporate Website
  • ع
  • IR Library
    • Results Center
    • Presentations and Publications
    • Board and Shareholders Actions
    • Our People
  • Share & Corporate Information
    • Key Information
    • Listing Information
    • Analyst Coverage
  • News and Disclosures
    • Corporate News
    • Regulatory Disclosures
  • IR Calendar
  • Corporate Governance
    • BOD Reports
    • Corporate Governance Reports
  • IR Contact

Yearly Archives: 2021

You are here:
  1. Home
  2. 2021

EGX Disclosure on BOD and shareholding structure

Regulatory DisclosuresBy adminJuly 12, 2021

Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E.’s Chief Executive Officer, Dr. Amr Morsy, recognized among the top 100 Arabian CEOs of 2020

Corporate NewsBy adminJune 27, 2021

Disclosure to EGX on EGM minutes

Regulatory DisclosuresBy adminMay 19, 2021

Disclosure to EGX on BOD minutes

Regulatory DisclosuresBy adminMay 6, 2021

Rameda Reports its 1Q21 Results

Corporate NewsBy adminMay 6, 2021

EGX disclosure regarding the upcoming EGM on 19 May 2021

Regulatory DisclosuresBy adminApril 21, 2021

Disclosure to EGX on OGM minutes

Regulatory DisclosuresBy adminApril 18, 2021

EGX Disclosure on BOD and shareholding structure

Regulatory DisclosuresBy adminApril 7, 2021

EGX disclosure regarding the upcoming EGM/OGM on 18 April 2021

Regulatory DisclosuresBy adminMarch 25, 2021

EGX Disclosure regarding Rameda’s Governance Report

Regulatory DisclosuresBy adminMarch 25, 2021
←123→

All Rights Reserved © 2024

Go to Top